EKSO Q2 2017 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q2 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$2M+20.3% YoY

Gross Profit

$396,00021.2% margin

Operating Income

-$8M-453.1% margin

Net Income

-$6M-295.0% margin

EPS (Diluted)

$-3.24

QoQ Revenue Growth

+30.0%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$711,000

Balance Sheet

Total Assets

$19M

Total Liabilities

$17M

Stockholders' Equity

$2M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+20.3%
Gross Profit	$396,000	$203,000	+95.1%
Operating Income	-$8M	-$7M	-14.4%
Net Income	-$6M	-$6M	+4.5%

Revenue Segments

Medical

$2M79%

Industrial

$365,00019%

Engineering Services

$28,0001%

Geographic Segments

United States

$1M55%

All Other

$836,00045%